Inviragen Lands $5,455,200 New Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dc7d1059-88f1-4072-a018-540d7efc79c2&Preview=1
Date
12/31/2010
Company Name
Inviragen
Mailing Address
1613 Prospect Pkwy. Fort Collins, CO 80525
Company Description
Inviragen, Inc. is committed to developing safe, effective vaccines to address this need. Inviragen is focused on developing life-saving vaccines to protect against emerging infectious diseases worldwide.
Website
http://www.inviragen.com
Transaction Type
Venture Equity
Transaction Amount
$5,455,200
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed.
M&A Terms
Venture Investor
Edbi
Venture Investor
Charter Life Sciences Fund
Venture Investor
Venture Investors
Venture Investor
Undisclosed